Skip to main content

Moderna, Inc.

MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001682852

In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $49.2M in total
Insiders trading
4
Net value
−$49.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Moderna, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hoge StephenPresident1,562,029Sep 16, 202613
Mock James MChief Financial Officer59,375Sep 14, 202616
Klinger Shannon ThymeChief Legal Officer81,340Sep 8, 202612
Bancel StephaneChief Executive Officer6,440,260Aug 7, 20264
McDonnell Michael RDirector–Jul 10, 20261
Banque Soria EsterChief Commercial Officer–Jul 7, 20261
Afeyan NoubarDirector3,924IndirectMay 22, 20263
Tallett Elizabeth EDirector4,761May 8, 20262
Nader FrancoisDirector32,781May 8, 20262
Rubenstein David M.Director9,643May 8, 20262
Nabel Elizabeth GDirector19,317May 8, 20262
Horning SandraDirector18,585May 8, 20262
Hussain AbbasDirector12,066May 8, 20264
Sagan PaulDirector312,027IndirectMay 1, 20250
Langer RobertDirector11,467,664May 7, 20240
Berenson StephenDirector22,203May 7, 20240
Garay ArpaChief Commercial Officer3,690Dec 7, 20230
Andres JuanSee remarks12,803Dec 30, 20220
Burton PaulChief Medical Officer954Nov 8, 20220
Meline David WChief Financial Officer2,857Aug 11, 20220
Zaks Tal ZviChief Medical Officer0Jul 2, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 3, 2023 (view filing)Mar 12 daysAfeyan NoubarDirectorSSale−10.0K$139.00−$1.39M−0.5%2.19M after
Mar 2, 2023 (view filing)Mar 11 dayHoge StephenPresidentSSale−1.07K$138.03−$148.0K−0.1%1.63M after
Feb 24, 2023 (view filing)Feb 22-232 daysBancel StephaneChief Executive OfficerSSale−80.0K$152.48−$12.2M−1.5%5.41M after10 lots
Feb 24, 2023 (view filing)Feb 222 daysAfeyan NoubarDirectorSSale−10.0K$160.35−$1.60M−0.5%2.20M after
Feb 17, 2023 (view filing)Feb 15-162 daysBancel StephaneChief Executive OfficerSSale−80.0K$174.02−$13.9M−1.5%5.41M after7 lots
Feb 17, 2023 (view filing)Feb 152 daysAfeyan NoubarDirectorSSale−10.0K$173.17−$1.73M−0.5%2.21M after
Feb 13, 2023 (view filing)Feb 103 daysHoge StephenPresidentSSale−245$163.90−$40.2K0.0%1.63M after
Feb 10, 2023 (view filing)Feb 8-92 daysBancel StephaneChief Executive OfficerSSale−80.0K$165.79−$13.3M−1.5%5.41M after11 lots
Feb 10, 2023 (view filing)Feb 82 daysAfeyan NoubarDirectorSSale−20.0K$167.84−$3.36M−0.9%2.22M after5 lots
Feb 3, 2023 (view filing)Feb 1-22 daysBancel StephaneChief Executive OfficerSSale−80.0K$172.16−$13.8M−1.5%5.41M after14 lots
Jan 27, 2023 (view filing)Jan 25-262 daysBancel StephaneChief Executive OfficerSSale−80.0K$191.38−$15.3M−1.5%5.41M after10 lots
Jan 27, 2023 (view filing)Jan 252 daysAfeyan NoubarDirectorSSale−10.0K$194.33−$1.94M−0.4%2.24M after
Jan 20, 2023 (view filing)Jan 18-192 daysBancel StephaneChief Executive OfficerSSale−80.0K$195.01−$15.6M−1.5%5.41M after15 lots
Jan 20, 2023 (view filing)Jan 182 daysAfeyan NoubarDirectorSSale−10.0K$200.20−$2.00M−0.4%2.25M after
Jan 13, 2023 (view filing)Jan 11-122 daysBancel StephaneChief Executive OfficerSSale−80.0K$185.26−$14.8M−1.5%5.41M after9 lots
Jan 13, 2023 (view filing)Jan 112 daysAfeyan NoubarDirectorSSale−10.0K$188.57−$1.89M−0.4%2.26M after
Jan 6, 2023 (view filing)Jan 4-52 daysBancel StephaneChief Executive OfficerSSale−80.0K$175.84−$14.1M−1.5%5.41M after9 lots
Jan 6, 2023 (view filing)Jan 42 daysAfeyan NoubarDirectorSSale−10.0K$182.15−$1.82M−0.4%2.27M after
Dec 30, 2022 (view filing)Dec 28-292 daysBancel StephaneChief Executive OfficerSSale−80.0K$178.42−$14.3M−1.5%5.41M after9 lots
Dec 30, 2022 (view filing)Dec 291 dayBancel StephaneChief Executive OfficerSSale−10.0K$178.19−$1.78M−0.2%6.56M after
Dec 30, 2022 (view filing)Dec 282 daysAndres JuanSee remarksSSale−2.00K$180.00−$360.0K−13.5%12.8K after
Dec 23, 2022 (view filing)Dec 21-222 daysBancel StephaneChief Executive OfficerSSale−80.0K$206.20−$16.5M−1.5%5.41M after14 lots
Dec 23, 2022 (view filing)Dec 221 dayBancel StephaneChief Executive OfficerSSale−10.0K$209.82−$2.10M−0.2%6.57M after
Dec 23, 2022 (view filing)Dec 212 daysAndres JuanSee remarksSSale−2.00K$201.70−$403.4K−13.5%12.8K after
Dec 23, 2022 (view filing)Dec 212 daysAfeyan NoubarDirectorSSale−10.0K$201.70−$2.02M−0.4%2.28M after
Dec 16, 2022 (view filing)Dec 14-152 daysBancel StephaneChief Executive OfficerSSale−80.0K$208.76−$16.7M−1.5%5.41M after20 lots
Dec 16, 2022 (view filing)Dec 151 dayBancel StephaneChief Executive OfficerSSale−10.0K$207.88−$2.08M−0.2%6.58M after
Dec 16, 2022 (view filing)Dec 142 daysAndres JuanSee remarksSSale−2.00K$195.00−$390.0K−13.5%12.8K after
Dec 16, 2022 (view filing)Dec 142 daysAfeyan NoubarDirectorSSale−10.0K$195.00−$1.95M−0.4%2.29M after
Dec 9, 2022 (view filing)Dec 72 daysAndres JuanSee remarksSSale−2.00K$172.16−$344.3K−13.5%12.8K after
Dec 9, 2022 (view filing)Dec 7-82 daysBancel StephaneChief Executive OfficerSSale−80.0K$180.47−$14.4M−1.5%5.41M after10 lots
Dec 9, 2022 (view filing)Dec 81 dayBancel StephaneChief Executive OfficerSSale−10.0K$179.12−$1.79M−0.2%6.59M after
Dec 9, 2022 (view filing)Dec 81 dayKlinger Shannon ThymeChief Legal OfficerSSale−490$179.15−$87.8K−9.3%4.77K after
Dec 9, 2022 (view filing)Dec 72 daysAfeyan NoubarDirectorSSale−10.0K$172.16−$1.72M−0.4%2.30M after
Dec 2, 2022 (view filing)Nov 30-Dec 12 daysBancel StephaneChief Executive OfficerSSale−80.0K$176.64−$14.1M−1.5%5.41M after13 lots
Dec 2, 2022 (view filing)Dec 11 dayBancel StephaneChief Executive OfficerSSale−10.0K$173.41−$1.73M−0.2%6.60M after
Dec 2, 2022 (view filing)Nov 302 daysAndres JuanSee remarksSSale−2.00K$173.52−$347.0K−13.5%12.8K after
Dec 2, 2022 (view filing)Nov 302 daysAfeyan NoubarDirectorSSale−10.0K$173.52−$1.74M−0.4%2.31M after
Nov 30, 2022 (view filing)Nov 291 dayAndres JuanSee remarksSSale−814$173.80−$141.5K−6.0%12.8K after
Nov 30, 2022 (view filing)Nov 291 dayHoge StephenPresidentSSale−1.08K$173.80−$188.6K−0.1%1.63M after
Nov 28, 2022 (view filing)Nov 253 daysBancel StephaneChief Executive OfficerSSale−40.0K$176.04−$7.04M−0.7%5.41M after4 lots
Nov 28, 2022 (view filing)Nov 253 daysBancel StephaneChief Executive OfficerSSale−10.0K$175.01−$1.75M−0.2%6.61M after
Nov 25, 2022 (view filing)Nov 232 daysBancel StephaneChief Executive OfficerSSale−40.0K$176.20−$7.05M−0.7%5.41M after5 lots
Nov 25, 2022 (view filing)Nov 232 daysAndres JuanSee remarksSSale−2.00K$178.01−$356.0K−14.5%11.8K after
Nov 25, 2022 (view filing)Nov 232 daysAfeyan NoubarDirectorSSale−10.0K$178.01−$1.78M−0.4%2.32M after
Nov 18, 2022 (view filing)Nov 162 daysAndres JuanSee remarksSSale−2.00K$184.25−$368.5K−14.5%11.8K after
Nov 18, 2022 (view filing)Nov 16-172 daysBancel StephaneChief Executive OfficerSSale−80.0K$183.52−$14.7M−1.5%5.41M after9 lots
Nov 18, 2022 (view filing)Nov 171 dayBancel StephaneChief Executive OfficerSSale−10.0K$181.33−$1.81M−0.2%6.62M after
Nov 18, 2022 (view filing)Nov 162 daysAfeyan NoubarDirectorSSale−10.0K$184.25−$1.84M−0.4%2.33M after
Nov 14, 2022 (view filing)Nov 9-105 daysBancel StephaneChief Executive OfficerSSale−80.0K$165.65−$13.3M−1.5%5.41M after13 lots